SUBSCRIBE
SUBSCRIBE
News   Deals

Procter & Gamble to Buy Israel’s ConTipi for up to $100 Mln

September 16, 2010 | 
1 min read
TEL AVIV, Sept 16 (Reuters) - Procter & Gamble (PG.N) will pay up to $100 million to acquire Israeli medical device firm ConTipi, a developer of disposable inserts to prevent urinary incontinence in women, the Maariv daily said on Thursday.
Mergers & acquisitions Asia
MORE ON THIS TOPIC
Creative collage illustration of financial business. Two businessmen shaking hands for partners agreement. Conceptual illustration of success deal, corporate ethic, connection.
Collaboration
Kite Makes $1.5B+ Cell Therapy Pact With Pregene as Others Pull Back
October 17, 2025
 · 
2 min read
 · 
Tristan Manalac
Gentilly, France, March 21, 2021: Exterior view of the Sanofi headquarters building. Sanofi is a French multinational company specializing in the health sector
Autoimmune disease
Sanofi Joins With EVOQ in $500M Autoimmune Alliance
October 16, 2025
 · 
2 min read
 · 
Tristan Manalac
Facade of Novo Nordisk's office in Fremont, California
Rare diseases
Novo Offers up to $2.1B for Omeros’ Complement Drug To Expand Rare Disease Work
October 15, 2025
 · 
2 min read
 · 
Dan Samorodnitsky
Pictured: Bristol Myers Squibb office in California
ALS
BMS Deepens ALS Alliance With Insitro, Puts $2B+ On the Line
October 15, 2025
 · 
1 min read
 · 
Tristan Manalac